Some of our leading cancer researchers, Professor Phil Hansbro, Professor Peter Hersey, Dr Mainthan Palendira and Dr Jessamy Tiffen have presented their project updates and recent findings to consumers and supporters at our recent consumer engagement session.
The projects, all funded by Cancer Council NSW, covered the critical health areas of melanoma (the most deadly form of skin cancer) and lung cancer.
The engagement sessions allow Centenary scientists to connect directly with the community and ensures that consumers are an integral part of the total research process.
Updates provided at the session were:
The Centenary Institute would like to thank all consumers and attendees at this session for their interest in improving human health outcomes, and continuing support of our life-saving medical research activities.
Professor John Rasko AO has led a world-first clinical trial into engineered stem cell treatment use, treating 15 patients with steroid resistant acute graft-versus-host disease.
Centenary Institute research has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.
Research led by the Centenary Institute has shown that a healthy weight and coffee consumption may help lower the risk of high-risk drinkers developing alcohol-induced cirrhosis.